UBS ASSET MANAGEMENT AMERICAS LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 136 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q3 2018$136,670,000
-2.3%
80,3940.0%0.00%
Q2 2018$139,886,000
-4.9%
80,3940.0%0.00%
Q1 2018$147,121,000
-17.9%
80,3940.0%0.00%
Q4 2017$179,278,000
-23.1%
80,3940.0%0.00%
Q3 2017$233,142,000
-33.5%
80,394
+2.1%
0.00%
Q2 2017$350,566,000
-4.3%
78,779
+0.2%
0.00%
Q1 2017$366,444,000
+112652.0%
78,636
+47.4%
0.00%
Q4 2016$325,0000.0%53,336
-9.3%
0.00%
Q3 2016$325,000
+92.3%
58,836
+32.5%
0.00%
Q2 2016$169,000
+37.4%
44,4000.0%0.00%
Q1 2016$123,000
-56.4%
44,400
-10.7%
0.00%
Q4 2015$282,000
-91.6%
49,700
-92.2%
0.00%
-100.0%
Q3 2015$3,365,000
-36.5%
634,900
-0.6%
0.00%
-20.0%
Q2 2015$5,301,000
+80.6%
638,700
+0.5%
0.01%
+66.7%
Q1 2015$2,936,000
+52.1%
635,400
+0.4%
0.00%
+50.0%
Q4 2014$1,930,000
+11.8%
632,800
+2.1%
0.00%0.0%
Q3 2014$1,726,000
-31.6%
619,8000.0%0.00%
-33.3%
Q2 2014$2,523,000
-23.3%
619,8000.0%0.00%
-25.0%
Q1 2014$3,291,000
-5.7%
619,8000.0%0.00%0.0%
Q4 2013$3,489,000
+22.2%
619,800
-0.8%
0.00%0.0%
Q3 2013$2,855,000624,7000.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,009,984$16,683,0006.50%
DAFNA Capital Management LLC 317,563$2,636,0002.23%
Trellus Management Company, LLC 162,900$1,352,0001.53%
PURA VIDA INVESTMENTS, LLC 246,250$2,246,0001.15%
WALL STREET ASSOCIATES 861,200$7,148,0000.67%
EAM Investors, LLC 670,346$5,564,0000.65%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 200,000$1,660,0000.58%
CARL DOMINO INC 66,900$555,0000.38%
Belmont Global Advisors, Inc. 36,200$300,0000.33%
Lombard Odier Asset Management (USA) Corp 507,223$4,210,0000.30%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders